W.R. Grace & Co. (GRA)
(Delayed Data from NYSE)
$76.51 USD
+0.99 (1.31%)
Updated May 3, 2019 04:02 PM ET
After-Market: $76.46 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$76.51 USD
+0.99 (1.31%)
Updated May 3, 2019 04:02 PM ET
After-Market: $76.46 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Analysts Estimate W.R. Grace (GRA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
W.R. Grace (GRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
W.R. Grace (GRA) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
W.R. Grace (GRA) delivered earnings and revenue surprises of 1.75% and 1.91%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings Slated on Jul 25: APD, EMN, AXTA, GRA
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings releases.
W.R. Grace (GRA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
W.R. Grace (GRA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Valmont's (VMI) Earnings & Sales Surpass Estimates in Q1
by Zacks Equity Research
Valmont's (VMI) Engineered Support Structures segment gains from improved pricing along with higher volumes in North America.
Arconic's (ARNC) Earnings Top, Sales Miss Estimates in Q1
by Zacks Equity Research
Arconic's (ARNC) Engineered Products and Solutions unit benefits from volume growth in aerospace engines as well as defense in Q1.
Methanex (MEOH) Q1 Earnings Beat Estimates, Revenues Lag
by Zacks Equity Research
Methanex (MEOH) saw lower average realized prices for methanol in Q1. It expects adjusted EBITDA to be lower sequentially in Q2.
Reliance Steel (RS) Earnings Top, Sales Miss Estimates in Q1
by Anindya Barman
Reliance Steel (RS) witness a healthy demand environment and favorable metal pricing conditions during the first quarter.
Cleveland-Cliffs (CLF) Earnings & Sales Top Estimates in Q1
by Zacks Equity Research
Cleveland-Cliffs' (CLF) revenue rate per ton declines in Q1. The company backs its full-year sales and production volume guidance.
LyondellBasell's (LYB) Q1 Earnings Top Estimates, Sales Trail
by Anindya Barman
LyondellBasell (LYB) benefited from improved market demand in the first quarter.
Eastman Chemical's (EMN) Q1 Earnings, Revenues Lag Estimates
by Zacks Equity Research
Eastman Chemical (EMN) saw lower sales across all segments in Q1. The company backed its adjusted earnings guidance for 2019.
Freeport (FCX) Misses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Lower copper production and prices hurt Freeport's (FCX) results in Q1.
Can Global Industrial Unit Fuel Ecolab's (ECL) Q1 Earnings?
by Zacks Equity Research
Expected sales growth across segments, product innovation and accelerating pricing are likely to aid Ecolab (ECL) in Q1. However, forex might play spoilsport.
Celanese's (CE) Q1 Earnings Top Estimates, Revenues Trail
by Zacks Equity Research
Lower volumes and prices hurt Celanese's (CE) revenues in the first quarter. The company reaffirms its earnings guidance for 2019.
W.R. Grace (GRA) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
W.R. Grace (GRA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WestRock (WRK) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Gains from favorable demand and the Kapstone acquisition will likely be offset by higher maintenance downtime and input cost inflation in WestRock's (WRK) second-quarter fiscal 2019 results.
3 Chemical Stocks Worth Betting on Before Their Q1 Earnings
by Anindya Barman
We have shortlisted three chemical stocks that are worth investing before the Q1 earnings season hits full throttle.
Here's Why You Should Hold Onto Sherwin-Williams Stock Now
by Zacks Equity Research
Sherwin-Williams (SHW) gains from significant synergies from the Valspar acquisition and growth through retail expansion.
Why Should You Add W. R. Grace (GRA) to Your Portfolio Now?
by Zacks Equity Research
Let's see what makes W. R. Grace (GRA) an attractive investment option at the moment.
Here's Why You Should Hold Onto Albemarle (ALB) Stock for Now
by Zacks Equity Research
Albemarle (ALB) to gain from strength in the lithium business and expansion actions.
Why Should You Hold Onto Eastman Chemical Stock for Now?
by Zacks Equity Research
Eastman Chemical (EMN) is benefiting from growth of its high-margin specialty business and cost management actions.
Here's Why You Should Buy Arconic (ARNC) Stock Right Now
by Zacks Equity Research
Let's take a look into the factors that make Arconic (ARNC) a compelling investment option at the moment.
Here's Why Innospec (IOSP) Stock is a Solid Choice Right Now
by Zacks Equity Research
Let's see what makes Innospec (IOSP) a compelling investment option at the moment.
Ingevity (NGVT) Up 52% in a Year: What's Driving the Rally?
by Zacks Equity Research
Let's take a look into the factors that are driving specialty chemicals maker,Ingevity (NGVT).
Chemicals Remain on Soft Footing With Sluggish Output Growth
by Anindya Barman
Global chemical production rises a paltry 0.1% on a monthly comparison basis in February.